Organic Active Ingredients TRIZ Cases

Alkaline EDTA chelates metal ions to dismantle multidrug-resistant biofilms, addressing limited efficacy of current cystic fibrosis therapies.

Antibodies bind RSV fusion protein to neutralize infection, lowering dosage requirements while maintaining prophylaxis efficacy.

Non-ionic poloxamer surfactants replace conventional anionic types in PHMB formulations, preventing microbicidal inactivation and reducing cytotoxicity.

Replacing high-pressure liquid chromatography with gravity-driven flow reduces production costs while achieving USP-grade purity.

Phosphorodiamidate morpholino oligonucleotides hybridize to LMNA pre-mRNA, blocking cellular splicing machinery recognition and reducing progerin accumulation.

Compound I resolves efficacy-complexity trade-offs by selectively targeting pathological immune responses while maintaining manageable dosing protocols.

Kinesin-1 inhibitors target KLC1C to disrupt lateral border recycling compartment dynamics in endothelial cells.

Porous decellularized extracellular matrix scaffolds resolve low loading capacity and mismatched kinetics in cardiac drug delivery.

Arylpiperazine derivatives stabilize dopamine and serotonin levels to improve cognitive symptoms without cardiac risks.

A chitosan and anionic polymer hydrogel forms a physically cross-linked network through electrostatic interactions.

Segmented GalNAc-conjugated oligonucleotides reduce viral load while inducing seroconversion without interferon side effects.

Casein phosphopeptide encapsulates PUFA salts to resolve oxidative instability and odor issues without emulsification.

Adaptable chimeric antigen receptor binds modified self-antigens via a biotin-linker conjugate to recruit immune cells against cancer.

Oxygen insertion and carboxyl substitution prevent beta-oxidation and auto-oxidation, ensuring metabolic stability for treating cardiac arrhythmias.

Single-dose combination of netupitant, palonosetron, and dexamethasone sustains NK1 receptor occupancy to prevent chemotherapy-induced nausea and vomiting.

Controlled crystallization before spray drying preserves drug stability and improves delivery efficiency.

Specific heterocyclic compounds inhibit the PD-1/PD-L1 interaction, resolving immune evasion capability issues by disrupting the inhibitory signaling cascade.

Pyrazolo[3,4-b]pyridine scaffolds with defined substituents achieve selective CDK inhibition to reduce off-target toxicity.

A tetrahydropyranyl amino-pyrrolopyrimidinone compound modulates Bruton's tyrosine kinase activity.

Administering CB2 receptor agonists reduces serum immunoglobulin E production, addressing ineffective current methods for managing allergic responses.

Ethanol-water crystallization produces orthorhombic asenapine maleate, enabling reproducible micronization without polymorphic contamination.

Novel tetrahydro-azafluorene analogs inhibit hepatitis C virus entry, addressing inadequate existing treatments.

A microwave vacuum system pasteurizes and dehydrates cannabis plant material using dielectric heating at reduced pressure.

Targeting PI5P4K with selective inhibitors addresses insufficient inhibition in p53-mutated cancers while avoiding perinatal lethality.

Multi-ligand drug conjugates bind multiple cell surface receptors to reduce toxicity while delivering payloads.

Formula I compounds target the NS5A protein to achieve sustained viral load reduction where standard interferon regimens fail.

Polymer gel stabilizes hydrophobic oils to provide sustained pain relief without systemic side effects.

Hexyl laurate mediates ultraviolet absorbent migration to skin, preventing dermatitis without reducing adhesiveness or causing discoloration.

Catalytic reduction of amine derivatives using precise pH and temperature parameters to achieve high yield.

Oral docarpamine prodrug bypasses diuretic resistance in cirrhosis by targeting proximal tubule sodium reabsorption.

Spray drying produces amcipatricin diascorbate powder to treat resistant Candida auris and mucormycosis infections.

SELEX-selected DNA aptamers block DEK activity, resolving small-molecule discovery limits.

A humic acid preparation binds glyphosate molecules in the gastrointestinal tract.

Lipo-polyamino acid conjugates extend plasma half-life while maintaining high transfection efficiency.

Direct intratumour injection of chemotherapeutic agents in biocompatible carriers reduces systemic toxicity and improves treatment efficacy.

Anti-CD79b antibodies conjugated to pyrrolobenzodiazepine via protease-sensitive linkers resolve targeting specificity trade-offs in lymphoma therapy.

Formula I compounds block TRPC6 channels to reduce vascular leakage and improve organ function in bacterial or fungal sepsis.

Self-crosslinking methylcellulose eliminates calcium dependency, ensuring consistent satiety without pH constraints.

Inhaled lithium modulates protein kinase signaling to lower IL-8 and TNF-alpha levels, avoiding systemic toxicity from oral dosing.

Stable crystal form A of an FXR agonist compound reduces NAS scores and improves hepatic function.

Gene expression profiling identifies anergic T cells through specific molecular signatures.

Combining PD-1 antagonists with eribulin boosts anti-tumor immune responses in breast cancer and melanoma patients.

New polymorphic forms resolve hygroscopic degradation by reducing water absorption, ensuring consistent bioavailability for HIV treatment formulations.

Modified thiazolidinedione structures reduce PPARγ activation and sodium reabsorption side effects while maintaining insulin sensitivity.

An IL-4/IL-13 pathway inhibitor reduces eosinophil infiltration and improves esophageal distensibility in patients with moderate-to-severe eosinophilic esophagitis.

An azole compound targets the viral internal ribosome entry site to block protein synthesis.